Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2014
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 07 Jul 2014 New trial record